Drug intelligence / Profile preview

enamel matrix derivative

Development stage
Phase 4
Lead developer
Biora Therapeutics
Modality
Recombinant Proteins and Enzymes
Administration
Periodontal, Surgical
01

Overview

Enamel matrix derivative (EMD) is a purified extract of porcine fetal tooth material used to biomimetically stimulate the regeneration of soft and hard tissues surrounding teeth following tissue destruction. The biological basis for EMD's effectiveness stems from the discovery that enamel matrix proteins laid down by Hertwig's epithelial root sheath serve as precursors to acellular cementum during its formation (cementogenesis). This acellular cementum signals the development of periodontal ligament fibers, followed by new alveolar bone, leading to the formation of periodontal tissues[9]. EMD is primarily composed of amelogenins (90% of the proteins) and is believed to mimic the development of tooth supporting apparatus during tooth formation[1]. When applied to periodontal lesions, it creates a suitable environment for selective periodontal cell migration and attachment, which helps re-establish lost tooth supporting tissues[8]. The protein self-assembles into an insoluble three-dimensional matrix under physiologic conditions, and is degraded by enzymatic processes of normal wound healing[8].

Brand names
Emdogain
Other names
EMD
02

Targets

COL1 (Collagen type I)

Beyond the preview

Go deeper on enamel matrix derivative.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on enamel matrix derivative.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call